Scientists at UC San Francisco have developed a way to create cancer-fighting CAR-T cells directly inside the body, potentially avoiding the slow and extremely expensive process of removing, ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
SAN CARLOS, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the ...
A recent commentary article published in the New England Journal of Medicine highlights how targeted dietary manipulations could reprogram tumor biology. The possibility that diet could improve cancer ...
Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics for solid tumors, announced the close of its seed financing round, bringing the company’s total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results